Jeevan Scientific Technology Ltd

Fri 9/10/2026,13:35:0 | BSE : JSTL

₹84.001.55 (1.88%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 82.71

Previous Close

₹ 82.45

Volume

143186

Mkt Cap ( ₹ Cr)

₹ 167.32

High

₹ 85.50

Low

₹ 82.40

52 Week High

₹ 93.90

52 Week Low

₹ 37.00

Book Value Per Share

₹ 36.56

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Jeevan Scientific Technology Ltd

Your Vote -

Buy

88.89%

Hold

0.00%

Sell

11.11%

88.89%

9 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Jeevan Scientific Technology Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Jeevan Scientific - Closure Of The United States Food And Drug Administration (US FDA) Inspection Of JSTL And Issuance Of The

    1 Oct 2026, 2:35PM Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Outcome of AGM

    25 Sep 2026, 12:31PM Outcome of 28th Annual General Meeting held on 25-09-2026
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 12:36PM Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Reg. 34 (1) Annual Report.

    3 Sep 2026, 7:30PM 28th Annual report
  • Jeevan Scientific - 28Th Annual General Meeting Of The Company Is Schecduled To Be Held On 25.09.2026 At 10:00 A.M.

    3 Sep 2026, 7:25PM 28th Annual General meeting of the Company is scheduled to be held on 25.09.2026 at 10:00 a.m.
  • Jeevan Scientific - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclos

    13 Aug 2026, 3:34PM Statement on Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
  • Jeevan Scientific - Announcement under Regulation 30 (LODR)-Change in Management

    13 Aug 2026, 3:16PM Announcement under Regulation 30 (LODR)- change in management
  • Jeevan Scientific - Unaudited Financial Results (Standalone And Consoilidated) For The Quarter Ended 30.06.2026.

    13 Aug 2026, 3:02PM Unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026.
  • Jeevan Scientific - Board Meeting Outcome for Outcome Of The Board Meeting

    13 Aug 2026, 2:57PM Outcome of the Board Meeting held on 13.08.2026
  • Jeevan Scientific - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.08.2026.

    10 Aug 2026, 6:20PM Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to
  • Jeevan Scientific - Intimation Of Approval For Addition Of Beds To The Existing Approved Bioavailability/ Bioequivalence Cent

    1 Aug 2026, 6:58PM Intimation of Approval for addition of Beds to the Existing Approved Bioavailability/ Bioequivalence Center of Jeevan Scientific Technology Limited's
  • Jeevan Scientific - Information About The Successful Completion Of USFDA Inspection.

    24 Jul 2026, 12:18PM Information about the Successful Completion of USFDA Inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations, 2015.
  • Jeevan Scientific has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 8:20PM As of June 2026, 30.25% is owned by Indian Promoters and 69.75% by Public. <p align=justify> Top five Promoters holding highest number of shares of Je
  • Jeevan Scientific - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    16 Jul 2026, 5:58PM Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026.

Key fundamentals

Evaluate the intrinsic value of Jeevan Scientific Technology Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 84.878 59.1651 53.0407 54.4562 63.127
Liabilities 84.878 59.1651 53.0407 54.4562 63.127
Equity 19.919 15.834 15.4802 15.4802 15.3015
Gross Profit 8.4838 6.4661 4.3603 1.2908 17.0768
Net Profit 1.6501 0.7357 -1.0497 -3.003 12.2629
Cash From Operating Activities 2.555 2.9585 2.7389 -8.7668 27.0878
NPM(%) 3.05 1.68 -2.72 -8.3 21.68
Revenue 53.9313 43.6099 38.5017 36.178 56.5549
Expenses 45.4475 37.1438 34.1414 34.8872 39.4781
ROE(%) 2.26 1.01 -1.44 -4.12 16.84

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Jeevan Scientific Technology Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Prodocs Solutions Ltd 153.00 0.66 10.36 44.94 147.72 0.00
Tata Consultancy Services Ltd 2171.00 4.61 15.25 29846.90 13601.11 5.06
Accelya Solutions India Ltd 1040.00 -5.03 16.30 123.07 639.00 0.00
Allied Digital Services Ltd 111.50 13.14 16.65 466.01 101.71 1.37

Company Info

2006 - is a professionally managed company espoused to the cause of taming and tailoring information technology to suit the singular needs of the client organizations. - the products are designed and built by the company such as Communication systems, Control Systems, Consumer Eleletronics, Design Services. - the company provides services such as ERP solutions,Web solutions, Staff Augmentation and BPO services 2011 -The Company has changed its name from Jeevan Softech Ltd to Jeevan Scientific Technology Ltd. 2014 -Jeevan has acquired new facility in Near Lanco Hills, Hyderabad. -Mr. Rajendra Prasad has been appointed as a whole time Director of the company. 2015 -"Bioanalytical Facility" from Directorate General of Health Services Office of Drug Controller General (India) (Drugs Control Section). -Workshop on Pharmacokinetics and Biostatistics -Jeevan has attended the 8th International Annual Conference on "Translational Clinical Pharmacology Research in Drug Development" in Mumbai -Jeevan Scientific New IT Division -Jeevan Scientific is now registered with USFDA as "Self-identified"; site following GDUFA 2012 act. -ENHOPS Solutions Pvt Ltd, a wholly owned subsidiary company of Jeevan Scientific Technology Ltd. has been formed. -Jeevan Scientific has participated in CPHI worldwide conference at Spain -Jeevan Scientific has participated in CPHI conference at India 2016 - Jeevan Scientific Technology Ltd Amendment to the Memorandum of Association of the Company. - The Company's Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the Office of Drug Control General, India (DCGI) 2017 -Successfully completed our First USFDA inspection to Bioanalytical facility. Concluded with no 483. 2019 -Reached mark of 200 studies in a span of 2 years from the date of initiation of our first full scope BE study in Feb 2017 2020 -Jeevan Scientific has established an exceptional and complex service portfolio of GLUCOSE CLAMPING TECHNIQUE PHASE I UNIT.2025-Acquisition of M/s. Naya Pharma Private Limited

2006 - is a professionally managed company espoused to the cause of taming and tailoring information technology to suit the singular needs of the client organizations. - the products are designed and built by the company such as Communication systems, Control Systems, Consumer Eleletronics, Design Services. - the company provides services such as ERP solutions,Web solutions, Staff Augmentation and BPO services 2011 -The Company has changed its name from Jeevan Softech Ltd to Jeevan Scientific Technology Ltd. 2014 -Jeevan has acquired new facility in Near Lanco Hills, Hyderabad. -Mr. Rajendra Prasad has been appointed as a whole time Director of the company. 2015 -"Bioanalytical Facility" from Directorate General of Health Services Office of Drug Controller General (India) (Drugs Control Section). -Workshop on Pharmacokinetics and Biostatistics -Jeevan has attended the 8th International Annual Conference on "Translational Clinical Pharmacology Research in Drug Development" in Mumbai -Jeevan Scientific New IT Division -Jeevan Scientific is now registered with USFDA as "Self-identified"; site following GDUFA 2012 act. -ENHOPS Solutions Pvt Ltd, a wholly owned subsidiary company of Jeevan Scientific Technology Ltd. has been formed. -Jeevan Scientific has participated in CPHI worldwide conference at Spain -Jeevan Scientific has participated in CPHI conference at India 2016 - Jeevan Scientific Technology Ltd Amendment to the Memorandum of Association of the Company. - The Company's Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the Office of Drug Control General, India (DCGI) 2017 -Successfully completed our First USFDA inspection to Bioanalytical facility. Concluded with no 483. 2019 -Reached mark of 200 studies in a span of 2 years from the date of initiation of our first full scope BE study in Feb 2017 2020 -Jeevan Scientific has established an exceptional and complex service portfolio of GLUCOSE CLAMPING TECHNIQUE PHASE I UNIT.2025-Acquisition of M/s. Naya Pharma Private Limited

Parent Organisation

Jeevan Scientific Technology Ltd.

Founded

02/02/1999

Managing Director

Mr.Krishna Kishore Kuchipudi

NSE Symbol

FAQ